Albendazole EP Impurity A is a benzimidazole-based triazole derivative arising from the synthetic pathway of albendazole. It features a 1H-benzimidazole-2-thiol core fused to a 4-propyl-1H-1,2,3-triazole ring, lacking the acetamide side chain present in the parent drug. The compound retains the thiol functionality and triazole heterocycle critical to the pharmacophore but exhibits altered electronic properties due to the absence of the terminal amide. This impurity forms via a nucleophilic attack of the benzimidazole thiolate on the propargyl triazole precursor, bypassing the final acetylation step. It serves as an HPLC reference standard for quantifying process-related impurities in albendazole active pharmaceutical ingredient batches.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1012554 โ | 25 mg | USD 730.00 |
CCCSC1=CC2=C(C=C1)N=C(N2)N
InChI=1S/C10H13N3S/c1-2-5-14-7-3-4-8-9(6-7)13-10(11)12-8/h3-4,6H,2,5H2,1H3,(H3,11,12,13)
RKMOQLOKJZARIG-UHFFFAOYSA-N